These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12712418)

  • 1. Comparative pharmacokinetics of coumarin anticoagulants L: Physiologic modeling of S-warfarin in rats and pharmacologic target-mediated warfarin disposition in man.
    Levy G; Mager DE; Cheung WK; Jusko WJ
    J Pharm Sci; 2003 May; 92(5):985-94. PubMed ID: 12712418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacokinetics of coumarin anticoagulants. XLIX: Nonlinear tissue distribution of S-warfarin in rats.
    Cheung WK; Levy G
    J Pharm Sci; 1989 Jul; 78(7):541-6. PubMed ID: 2778653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences in pharmacokinetics of oral warfarin in rats.
    Zhu X; Shin WG
    Biopharm Drug Dispos; 2005 May; 26(4):147-50. PubMed ID: 15776499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of rutin on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats.
    Chan E; Hegde A; Chen X
    J Pharm Pharmacol; 2009 Apr; 61(4):451-8. PubMed ID: 19298691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of microdosing to predict pharmacokinetics at the therapeutic dose: experience with 5 drugs.
    Lappin G; Kuhnz W; Jochemsen R; Kneer J; Chaudhary A; Oosterhuis B; Drijfhout WJ; Rowland M; Garner RC
    Clin Pharmacol Ther; 2006 Sep; 80(3):203-15. PubMed ID: 16952487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetics of coumarin anticoagulants XXIX: Elimination kinetics and anticoagulant activity of (S)-(-)-warfarin in rats before and after chronic administration.
    Yacobi A; Levy G
    J Pharm Sci; 1977 Sep; 66(9):1275-7. PubMed ID: 903865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cucurbitacin e, a tetracyclic triterpene compound from Cucurbitaceae, on the pharmacokinetics and pharmacodynamics of warfarin in rats.
    Ding T; Zhang Y; Chen A; Tang Y; Liu M; Wang X
    Basic Clin Pharmacol Toxicol; 2015 May; 116(5):385-9. PubMed ID: 25250504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steady-state clearance rates of warfarin and its enantiomers in therapeutically dosed patients.
    McAleer SD; Foondun AS; Feely M; Chrystyn H
    Chirality; 1997; 9(1):13-6. PubMed ID: 9094197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacokinetics of coumarin anticoagulants XLIII: Concentration-dependent hepatic uptake of warfarin in rats.
    Takada K; Levy G
    J Pharm Sci; 1979 Dec; 68(12):1569-71. PubMed ID: 529059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma pharmacokinetics of warfarin enantiomers in cats.
    Smith SA; Kraft SL; Lewis DC; Freeman LC
    J Vet Pharmacol Ther; 2000 Dec; 23(6):329-37. PubMed ID: 11168909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of etravirine on the pharmacokinetics and pharmacodynamics of warfarin in rats.
    John J; John M; Wu L; Hsiao C; Abobo CV; Liang D
    Br J Pharmacol; 2013 Apr; 168(8):1851-8. PubMed ID: 23215758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children.
    Takahashi H; Ishikawa S; Nomoto S; Nishigaki Y; Ando F; Kashima T; Kimura S; Kanamori M; Echizen H
    Clin Pharmacol Ther; 2000 Nov; 68(5):541-55. PubMed ID: 11103757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 5-fluorouracil on the anticoagulant activity and the pharmacokinetics of warfarin enantiomers in rats.
    Zhou Q; Chan E
    Eur J Pharm Sci; 2002 Oct; 17(1-2):73-80. PubMed ID: 12356422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of anticoagulant effect of warfarin caused by enantioselective metabolic inhibition by the uricosuric agent benzbromarone.
    Takahashi H; Sato T; Shimoyama Y; Shioda N; Shimizu T; Kubo S; Tamura N; Tainaka H; Yasumori T; Echizen H
    Clin Pharmacol Ther; 1999 Dec; 66(6):569-81. PubMed ID: 10613612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative pharmacokinetics of coumarin anticoagulants XLIV: Dose-dependent pharmacokinetics of warfarin in rats.
    Takada K; Levy G
    J Pharm Sci; 1980 Jan; 69(1):9-14. PubMed ID: 7354452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of a pharmacokinetic interaction between etanercept and warfarin.
    Zhou H; Patat A; Parks V; Buckwalter M; Metzger D; Korth-Bradley J
    J Clin Pharmacol; 2004 May; 44(5):543-50. PubMed ID: 15102876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Warfarin maintenance dose adjustment with indirect pharmacodynamic model in rats.
    Cao YG; Liu XQ; Chen YC; Hao K; Wang GJ
    Eur J Pharm Sci; 2007 Feb; 30(2):175-80. PubMed ID: 17169538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ubidecarenone on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats.
    Zhou S; Chan E
    Drug Metabol Drug Interact; 2001; 18(2):99-122. PubMed ID: 11460879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of tissue disposition data from rats and dogs to determine species differences in input parameters for a physiological model for perchloroethylene.
    Dallas CE; Chen XM; Muralidhara S; Varkonyi P; Tackett RL; Bruckner JV
    Environ Res; 1994 Oct; 67(1):54-67. PubMed ID: 7925194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacokinetics of coumarin anticoagulants. XIV: relationship between protein binding, distribution, and elimination kinetics of warfarin in rats.
    Yacobi A; Levy G
    J Pharm Sci; 1975 Oct; 64(10):1660-4. PubMed ID: 1195101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.